BridgeMD
New treatment option for Post-Concussion Syndrome
Official title Personalized Brain Stimulation to Treat Chronic Concussive Symptoms
ClinicalTrials.gov ID: NCT06073886
What this study is testing
- What it's testing
- The goal of this study is to investigate a new treatment for chronic symptoms after concussion or mild traumatic brain injury in people aged 18-65 years old. Chronic symptoms could include dizziness, headache, fatigue, brain fog, memory difficulty, sleep disruption, irritability, or anxiety that occurred or worsened after the injury.
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Mild traumatic brain injury (mTBI) defined in accord with the World Health Organization criteria in the last 12 months
- age 18-65 at the time of the mTBI
- high burden of post-concussive symptoms defined as a score \>=20 on the Rivermead Post-Concussion Symptoms Questionnaire
You likely can't join if
- objective neurologic deficits
- ongoing or prolonged (\>3 months) post-concussive symptoms from a prior mTBI within 2 years of the index injury
- history of transcranial magnetic stimulation (TMS) therapy
- contraindications for TMS or magnetic resonance imaging (MRI) (e.g., metallic implant other than dental, pacemaker)
- severe mental, physical, or medical problems that would impede participation or pose a risk for the planned intervention (e.g., liver, kidney, or...
- active alcohol or illicit drug abuse
See the full eligibility criteria
- Mild traumatic brain injury (mTBI) defined in accord with the World Health Organization criteria in the last 12 months
- age 18-65 at the time of the mTBI
- high burden of post-concussive symptoms defined as a score \>=20 on the Rivermead Post-Concussion Symptoms Questionnaire
- objective neurologic deficits
- ongoing or prolonged (\>3 months) post-concussive symptoms from a prior mTBI within 2 years of the index injury
- history of transcranial magnetic stimulation (TMS) therapy
- contraindications for TMS or magnetic resonance imaging (MRI) (e.g., metallic implant other than dental, pacemaker)
- severe mental, physical, or medical problems that would impede participation or pose a risk for the planned intervention (e.g., liver, kidney, or heart disease, uncontrolled diabetes or hypertension, malignancy...
- active alcohol or illicit drug abuse
- inability to speak and read English
The study team makes the final eligibility decision.
Where it's taking place
- Westwood, Los Angeles, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Westwood, Los Angeles, California, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.